Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact
Stoyanova Lab
  • Home
  • Research
  • Our Group
  • Alumni
  • Publications
  • News
  • Join Our Team
  • Donate
    • Sponsors
  • Contact

Discussion of the emergence and therapeutic potential for neuroendocrine prostate cancer

May 18, 2022
Dr. Shiqin Liu

The Stoyanova Lab discusses the molecular mechanisms that underly development of neuroendocrine phenotypes in prostate cancer. Congrats to Laura and the team!

https://pubmed.ncbi.nlm.nih.gov/35597438/

May 18, 2022

NewsStanford

FacebookXPinterestRedditDeliciousWhatsappEmail
  • PreviousDiscovery of SU086 as an inhibitor of glycolysis and a potential treatment strategy for advanced prostate cancer

  • NextDiscovery of a new metastasis model to assess the role of notch signaling in prostate cancer

Related Posts ...

Exciting News: Diana Argiles Castillo passed her qualifying examination and is now a PhD candidate

News

Exciting news: Dr. Shiqin (Laura) Liu awarded grant from Department of Defense to develop immunotherapy for neuroendocrine prostate cancer.

News

Logo

ADDRESS

Los Angeles
CA 90095, USA
tstoyanova@mednet.ucla.edu

+1 (310) 825 0955

QUICK LINKS

  • UCLA
  • UCLA Health
  • Positions Available
© Stoyanova Lab. All Rights Reserved. | admin login